Depending on the subgroup Investigation, we discovered that there was significant heterogeneity regarding mortality, favorable outcomes, and the overall cure successful rate. Relating to mortality, The main reason for heterogeneity over the subgroup of edaravone dexborneol and EDV was primarily attributed to variances in drug dosage. Regarding favorable outcomes, The https://buyneuroprotectivesonline00935.blogrelation.com/39463787/little-known-facts-about-what-are-the-best-neuroprotective-drugs